The project will develop a product innovation – the first in its class (first-in-class) drug candidate for use in the treatment of colorectal cancer. The target is to develop an effective drug, which will help with inhibition of tumor growth and stopping the metastatic colorectal cancer (CRC).
Application for project co-funding within European Union, European Regional Development Fund:
- Total project amount: 9,822,015.00 PLN
- Co-funding portion: 6,873,131.75 PLN